TAZIFYLLINE, (-)-

Details

Stereochemistry	UNKNOWN
Molecular Formula	C23H32N6O3S
Molecular Weight	472.604
Optical Activity	( - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CN1C2=C(N(CC(O)CN3CCN(CCCSC4=CC=CC=C4)CC3)C=N2)C(=O)N(C)C1=O

InChI

InChIKey=JTOUASWUIMAMAD-UHFFFAOYSA-N

InChI=1S/C23H32N6O3S/c1-25-21-20(22(31)26(2)23(25)32)29(17-24-21)16-18(30)15-28-12-10-27(11-13-28)9-6-14-33-19-7-4-3-5-8-19/h3-5,7-8,17-18,30H,6,9-16H2,1-2H3

HIDE SMILES / InChI

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Histamine H1 receptor 315 Target ID: P35367 Gene ID: 3269.0 Gene Symbol: HRH1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/2424463	Antagonist 2778

Name

Type

Language

TAZIFYLLINE, (-)-

Common Name

English

(-)-3,7-DIHYDRO-7-(2-HYDROXY-3-(4-(3-(PHENYLTHIO)PROPYL)-1-PIPERAZINYL)PROPYL)-1,3-DIMETHYL-1H-PURINE-2,6-DIONE

Common Name

English

1H-PURINE-2,6-DIONE, 3,7-DIHYDRO-7-(2-HYDROXY-3-(4-(3-(PHENYLTHIO)PROPYL)-1-PIPERAZINYL)PROPYL)-1,3-DIMETHYL-, (-)-

Systematic Name

English

(-)-TAZIFYLLINE

Common Name

English

Code System Code Type Description

FDA UNII

CT45R338RA

Created by admin on Sat Dec 16 01:43:01 GMT 2023 , Edited by admin on Sat Dec 16 01:43:01 GMT 2023

PRIMARY

CAS

113932-16-4

Created by admin on Sat Dec 16 01:43:01 GMT 2023 , Edited by admin on Sat Dec 16 01:43:01 GMT 2023

PRIMARY

SUBSTANCE RECORD


					CT45R338RA

TAZIFYLLINE, (-)-